In May 2024, researchers in Osaka, Japan, identified a resurgence of Pharyngoconjunctival Fever cases, particularly among children, after a COVID-19-related lull. Adenovirus type B3 was found to be the predominant strain, involved in more than 50% of recent cases. This resurgence highlights the post-pandemic rebound of viral infections and signals a renewed public health focus on adenovirus surveillance in pediatric populations
